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Background: Increasing recent evidence has implicated osteoporosis as a risk factor for benign paroxysmal positional
vertigo (BPPV). We conducted a systematic review to examine the association between osteoporosis and BPPV.
Methods: Four electronic databases (PubMed, EMBASE, Cochrane Library, and the China Network Knowledge
Infrastructure) were searched to identify all papers, published in either English or Chinese, examining the association
between osteoporosis (osteopenia) and BPPV.
Results: Seven studies were eligible for analysis, though these studies included some weaknesses. Most of the studies
demonstrated a correlation between osteoporosis (osteopenia) and the occurrence and recurrence of BPPV, especially in
older women. Patients with osteoporosis may require more canalith-repositioning procedures.
Conclusions: This systematic review provides insight into currently available evidence and elucidates the possible
existence of an association between BPPV and osteoporosis (osteopenia). However, the evidence supporting that
conclusion is not strong, and further studies are needed to clarify the association between these conditions.
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Dizziness and vertigo are among the most frequently en-
countered symptoms in primary care. Benign paroxys-
mal positional vertigo (BPPV) is the most commonly
diagnosed type of vertigo, and is characterized by short-
duration vertigo, nausea and/or positional nystagmus
associated with changes in head position. One epidemio-
logical study of the general population in Germany
conducted by von Brevern and his colleagues found that
2.4% of the population (3.2% of women, 1.6% of men)
experienced BPPV at some time during their lives [1].
Posterior canal BPPV is the most common type, ac-
counting for about 90% of cases, while lateral canal
BPPV accounts for about 8% [2]. In rare instances, the
anterior canal or multiple canals might be involved [3].
BPPV is thought to be caused by the presence of cupulo-
lithiasis or canalithiasis in one or more semicircular canals.
However, its exact etiology is unknown and, in most cases,
cannot be identified. It may also be secondary to various* Correspondence: zhangruxinent@126.com
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unless otherwise stated.other conditions, including head trauma [4], labyrinthitis
[5], Meniere’s disease [6,7], position during bed rest [8], and
migraine [9]. Increasing recent evidence has implicated
osteoporosis as a risk factor for BPPV, suggesting that med-
ications used to treat osteoporosis may also help to prevent
the occurrence and recurrence of BPPV. It is therefore
important to establish the nature of the relationship be-
tween osteoporosis and BPPV. The aim of this study was to
conduct the first systematic review to examine the associ-
ation between osteoporosis and BPPV.Methods
This study was granted an exception from ethics ap-
proval by the Ethics Committee of Shandong Qianfoshan
Hospital.Data sources
This review included studies published in English or
Chinese that examined the association between osteo-
porosis (osteopenia) and BPPV. The databases searched
were PubMed (1966–2013), EMBASE (1974–2013),
the Cochrane Library (Issue 3, 2013) and the China
Network Knowledge Infrastructure (1979–2013). AllThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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terms included “osteoporosis”, “osteopenia” combined
with “benign paroxysmal positional vertigo”, “benign
positional vertigo”, “BPPV”, and “BPV”. Two independ-
ent reviewers (SY and FL) evaluated the titles and ab-
stracts of all the studies identified in the initial search to
locate any potentially relevant studies. The full texts
of studies identified as potentially relevant by either re-
viewer were then evaluated in duplicate.
Inclusion and exclusion criteria
Studies were eligible if they met the following criteria:
studies examined the associations between osteoporosis
(osteopenia) and BPPV. In cases of multiple publications
of the same or overlapping cohorts, only the studies with
the largest sample size were included. The following
types of studies were excluded: reviews, commentaries,
case reports or letters; studies with insufficient reported
data and if the relevant information could not be ob-
tained by contacting the authors.
Data extraction and quality assessment
Hard copies of all articles included were obtained and
read in full. The two authors (SY and FL) extracted data
according to pre-defined criteria. Discrepancies were
noted and discussed between the authors, and resolved
by consensus. Data from the articles were validated and
extracted using a pre-defined data-extraction form. The
following data were recorded for each study: (1) year of
publication; (2) age of subjects; (3) number of subjects;
(4) study design; (5) percentages of men and women; (6)
outcomes evaluated; and (7) authors’ conclusions. Study
quality was evaluated using the Newcastle-Ottawa Scale
[10] to assess the risk of bias in individual studies. Each
study was evaluated for three broad perspectives using the
‘star system’: (1) selection of study groups; (2) comparability
of groups; and (3) ascertainment of the outcome of interest.
Study quality was graded as poor (1–3 stars), intermediate
(4–6 stars) or high (7–9 stars). Disagreements were re-
solved by discussions between all authors.
Results
Trial selection
After screening all titles, abstracts and full texts, the ini-
tial search strategy retrieved 92 publications for possible
inclusion in the systematic review. Among these 92 pub-
lications, seven publications met the inclusion criteria
and were retrieved for more in-depth evaluation
(Figure 1).
Description of studies
These seven papers (Table 1) represented seven unique
studies, each of which reported an analysis of the associ-
ation between osteoporosis (osteopenia) and BPPV. Twoof the seven studies were conducted in Korea [11,12],
two in the United States [13,14], one in Switzerland [15],
one in Japan [16], and one in Italy [17]. Two of the seven
studies were cohort studies [11,14] and five were case–
control studies. One of the seven was a retrospective
study [13] and the others were prospective studies.
These seven clinical studies included 1,631 BPPV pa-
tients and 402 healthy controls. All studies were pub-
lished in English. None of the trials were randomized
controlled trials (RCTs). Because of heterogeneity in
study design, data collection, data presentation and lack
of RCTs, we did not pool summary data in a meta-
analysis.
Study quality
As shown in Tables 2 and 3, two studies [12,17] were
graded as ‘high quality’ and five studies [11,13-16] were
graded as ‘intermediate quality’. No studies were graded
as ‘poor’. The two cohort studies had inadequate follow-
up. None of the five case–control studies reported the
non-response rate or used the general community as
controls. There were particular weaknesses in terms of
outcome ascertainment and the representative nature of
the cases.
Study findings
Five clinical studies [11,12,14-16] investigated the associ-
ation between bone mineral density (BMD) and BPPV.
BMD provides a measure of the amount of calcium in
areas of the bones, and is used as an indirect clinical in-
dicator of osteoporosis. All of these five studies demon-
strated an apparent correlation between BPPV and
decreased BMD score; four studies [11,12,14,15] found
an association between the occurrence of BPPV and
osteoporosis, two [11,16] reported that the prognosis of
BPPV might be clinically predicted by BMD reduction,
and one [13] reported a negative association between
BPPV and treated osteoporosis in women. These results
suggest that osteoporosis, or the medication used to
treat it, might provide protection against BPPV. In terms
of age, one study [15] demonstrated more obvious corre-
lations between BPPV and decreased BMD score in men
in their 50s and 70s, but not in their 60s, while another
study [11] found obvious correlations in all age groups.
Osteoporosis is common in women after menopause.
Among the seven clinical studies analyzed, the study
subjects in four [13-16] were postmenopausal women
(older women), another study [11] included adult
women (about half of them were postmenopausal), while
the remaining two studies [12,17] included adult men
and women. However, even in these adults, the inci-
dence of osteoporosis was higher in women than in
men, with female:male ratios of about 2:1 in these two
studies. Adequate intakes of calcium and vitamin D are
Figure 1 Flow chart depicting the method of study selection.
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strength. Vitamin D deficiency may contribute to the de-
velopment of osteoporosis. However, one study [14]
found no correlation between serum vitamin D levels
and the presence of BPPV.
Recurrence of BPPV is a frequent problem. Two stud-
ies [11,16] found that the recurrence rate was signifi-
cantly higher in patients with osteoporosis compared
with patients with normal bone mass; furthermore, the
frequency of BPPV recurrence increased as BMD de-
creased. Another study [12] also found that BMD was
lower in patients with recurrent BPPV compared with
patients with de novo BPPV, but only in women older
than 45 years, and not in men or younger women. One
study [17] found that osteoporosis was related to an in-
creased risk of relapsing BPPV when it was combinedwith comorbidities such as hypertension, diabetes, or
osteoarthrosis.
The canalith-repositioning procedure (CRP) is cur-
rently the main treatment for BPPV. Some patients may
require several CRPs, and one study [11] found that pa-
tients with lower BMD values underwent significantly
more CRPs.
Biochemical markers of bone turnover provide clinic-
ally useful evidence of the normal and pathologic pro-
cesses that reflect bone cell activity in the skeleton. The
assessment of bone turnover markers has been proposed
to supplement BMD measurement in the diagnosis of
osteoporosis. Only one study [14] assessed the associ-
ation between biochemical markers of bone turnover
and BPPV, and found that patients with BPPV had
higher amino-terminal propeptide of protocollagen type
Table 1 Summary of the seven studies that investigated the association between osteoporosis (osteopenia) and BPPV
Study Age range
(Mean ± SD)







50 to 85(69 ± 9.2) 32(BPPV):83(Healthy controls) Case–
control
study
All were Female BMD The apparent correlation between BPPV
and osteopenia or osteoporosis
Jang2009 [11] 20 to 69 78(BPPV):117 (Healthy controls) Cohort
studies
All were Female BMD, The number of canalith
repositioning maneuvers, The
presence of recurrence
Patients with BPPV had lower BMD values
compared with control subjects, and patients
with low BMD values showed a significant
increase in the number of canalith repositioning
maneuvers required and the recurrence rate
Jeong2009 [12] 29 to 90 years (59.8 ±
12.5 in test group, 56.3








BMD Decreased BMD score both in women




51 to 80 143(BPPV):117(Controls that with
symmetric sensorineural hearing loss





All were Female The presence or absence of
osteoporosis
There was a negative association between BPPV
and treated osteoporosis in women aged 51 to
60 years, and a trend towards a negative
association for women aged 61–70 years
and for the group as a whole. Osteoporosis,









All were Female BMD Osteoporosis is a risk factor for BPPV recurrence.
The prognosis of BPPV might be clinically
predicted by BMD reduction.
Parham2013
[14]
49 to 81 (66.9 ± 1.8) 16(BPPV):13(osteopenia/osteoporosis) Cohort
studies
All were Female BMD. Calcium, Vit D, 25(OH)
D3, and Serum Markers of
Bone Turnover (sNTX, P1NP)
Postmenopausal women with BPPV have a
high prevalence of osteopenia/osteoporosis,
and postmenopausal women with
osteopenia/osteoporosis have higher
than expected prevalence of BPPV. Levels of
biochemical markers of bone turnover correlate
with presence of BPPV but not Ca or Vit D.
Stefano2013
[17]








Risk of recurrence Combine with two or more comorbidities
(hypertension, diabetes, osteoarthrosis),
osteoporosis further increases the risk of
relapsing BPPV


















Table 3 Methodological quality assessment of case–control
































on the basis of the
design or analysis












6 7 5 6 7
Study quality was graded as poor (1–3 stars), intermediate (4–6 stars) or high
(7–9 stars).
Table 2 Methodological quality assessment of cohort
studies using the Newcastle-Ottawa Scale








Ascertainment of exposure ⋆ ⋆
Demonstration that outcome
of interest was not present
at start of study
⋆ ⋆
COMPARABILITY
Comparability of cohorts on




Ascertainment of exposure ⋆ ⋆
Was follow-up long enough
for outcomes to occur
Adequacy of follow up of cohorts
Total number of star 5 5
Study quality was graded as poor (1–3 stars), intermediate (4–6 stars) or high
(7–9 stars).
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bone turnover correlated with the presence of BPPV.
However, this study [14] also found no apparent correl-
ation between serum ionized calcium and the presence
of BPPV.
Discussion
This systematic review aimed to select all studies that
examined the association between osteoporosis (osteope-
nia) and BPPV. A total of seven studies were retrieved
and analyzed. The results indicate that BPPV may be as-
sociated with osteoporosis or osteopenia, and that the
medications used to treat these conditions may be able
to prevent the occurrence and recurrence of BPPV.
BPPV is the single most common cause of vertigo.
CRP provides an effective treatment for most BPPV pa-
tients, but the condition has a high recurrence rate; one
study found a recurrence rate for BPPV of about 27% in
the first 6 months [18]. It is therefore important to
gather information to help prevent the occurrence and
recurrence of BPPV. This systematic review elucidated
the association between osteoporosis and BPPV, and in-
dicated that medications used to treat osteoporosis (such
as calcium preparations) may help to prevent the occur-
rence and recurrence of BPPV.
This review was limited by the fact that the included
studies were cohort studies and case–control studies
(low evidence), mostly graded as ‘intermediate quality’,
and no RCTs (highest evidence) were identified. Studieswith a lower level of evidence have a higher risk of bias.
The association between osteoporosis and BPPV is bet-
ter suited to investigation using long-term, multicenter,
epidemiological studies. Although one study [17] was a
multicenter, observational study, it was not a long-term,
epidemiological study, and observational studies are subject
to selection, outcome and measurement biases. Further,
long-term, multicenter, epidemiological studies or RCTs are
therefore needed to confirm the current conclusions.
The subjects in most studies were women, especially
older women. The prevalence of BPPV has been shown
to be higher in women, and between the ages of 41 and
60 years [19]. Similarly, changes in hormone levels be-
tween these ages lead to osteoporosis/osteopenia. One
experimental study [20] found ultrastructural modifi-
cations of the otoconia in terms of their aspect, size
and density in ovariectomized osteopenic/osteoporotic
female adult rats. This mechanism may help to explain
the higher prevalence of BPPV in women. However,
BPPV can also occur at other ages and can occur in
men, and the role of osteoporosis in the occurrence of
BPPV in these groups remains unanswered. Another
experimental study [21] showed that degeneration of
the otoconia and linking filaments increased with age
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mechanism.
There were several limitations to our study. First, we
were unable to perform a meta-analysis because of the
lack of RCTs included in this review. Second, only seven
relevant studies were identified, with only a few provid-
ing evidence for the various outcomes. Third, we limited
our search to reports written in Chinese and English,
and it is possible that we missed relevant studies pub-
lished in other languages; however, this would have been
beyond the language skills of our team members, though
future studies should consider broadening the scope of
included papers.
Conclusions
In conclusion, this systematic review provides an insight
into the currently available evidence regarding an associ-
ation between osteoporosis and BPPV. However, although
analysis of the available studies suggests a possible associ-
ation between BPPV and osteoporosis (osteopenia), the
evidence to support that conclusion remains weak, and fur-
ther studies are needed to confirm the relationship between
these conditions.
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